✦ LIBER ✦

Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation

✍ Scribed by Orli Megged; Itamar Shalit; Isaac Yaniv; Jerry Stein; Salvador Fisher; Itzhak Levy

Book ID: 110896445
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 12
Category: Article
ISSN: 1397-3142
DOI: 10.1111/j.1399-3046.2007.00891.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of cerebral toxoplasmosis in a

Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients

✍ Hakko, E.; Ozkan, H.A.; Karaman, K.; Gulbas, Z. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

First case of breakthrough pulmonary Asp

First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation

✍ Jutta Auberger; Cornelia Lass-Flörl; Johannes Clausen; Romuald Bellmann; Walter 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Breakthrough fungal infections after all

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

✍ Trifilio, S; Singhal, S; Williams, S; Frankfurt, O; Gordon, L; Evens, A; Winter, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

The sulfone syndrome secondary to dapson

The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation

✍ Muneer H. Abidi; Jennifer R. Kozlowski; Rami B. Ibrahim; Edward Peres 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract Dapsone is commonly used for pneumocystis carinii pneumonia (PCP) prophylaxis in immunocompromised patients. It has been used as an alternative therapy in the hematopoietic stem cell transplant (HSCT) setting in patients who can't tolerate trimethoprim‐sulfamethoxazole. The Sulfone synd

243Pharmacoeconomics of prophylaxis for

243Pharmacoeconomics of prophylaxis for fungal infections in patients undergoing a hematopoietic stem cell transplant

✍ K.B. Tong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Alternate-Day Micafungin Antifungal Prop

Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study

✍ Parinda A. Mehta; Alexander A. Vinks; Alexandra Filipovich; Jack Bleesing; Sonat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 143 KB